Peter Bachmann,
PhD
Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board
Chair, CMDh, Federal Institute For Drugs and Medical Devices (BfArM)
Following a Japan Society for Promotion of Science Postdoctoral Fellowship at Kyoto University (Japan), and a German Research Foundation Fellowship at the Institute of Food Research in Norwich (UK), Dr. Bachmann worked at the Institute of Pharmaceutical Biology at the Technical University Braunschweig (Germany), until joining the German Federal Institute for Drugs and Medical Devices (BfArM) Department of Drug Approval in 1999.
Following positions as Head of Subunit, Variations (2000-2002), and Head of Unit Mutual Recognition Procedures (2002 -2005), Dr. Bachmann was appointed as Senior Expert for Drug Regulatory Affairs in the Cooperate Unit European and International Affairs. He currently serves as Head of the Unit of European Coordination and as Deputy-Head of the Division of European and International Affairs. He has served in the additional roles as well: German NtA Member since 2002; German representative to the Mutual Recognition Facilitation Group from 2002 – 2005; German Member of the Coordination Group for Mutual Recognition and Decentralised Procedures - human from 2005 – 2011; and is a member of other European and AdHoc Working Parties.
Dr. Bachmann is currently the elected chair of the Coordination Group for Mutual Recognition and Decentralised Procedures - human and a Member of the Scientific Coordination Board of the European Medicines Agency. He is a lecturer for Drug Regulatory Affairs at the Universities of Bonn, Duisburg-Essen, Basel and Copenhagen, an honorary member of the Middle-European Society for Regulatory Affairs, an honorary lifetime member of The Organisation for Professionals in Regulatory Affairs, and a former member of the DIA Advisory Committee of Europe (2007 – 2013). Dr. Bachmann studied biology and chemistry and has a Doctorate of Natural Sciences (Pharmaceutical Biology) from the University of Wuerzburg (Germany).
Our Leadership
-
Joseph Scheeren,
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
John A. Roberts,
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
Rebecca Vermeulen,
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
Jeffrey S. Payne,
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
Barbara Lopez Kunz,
MS • Global Chief Executive
DIA
-
Andrzej Czarnecki,
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
Angelika Joos,
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
Judith Ng-Cashin,
MD •Director DIA
Chief Scientific Officer
Syneos Health -
Michael Romano,
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
Michael Rosenblatt,
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
Jonathan Sheldon,
PhD •Director DIA
Senior Vice President
QIAGEN -
Kihito Takahashi,
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
Lingshi Tan,
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
Cynthia L. Verst,
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
Joseph Scheeren,
PharmD • Chair, Executive Committee
-
Jeffrey S. Payne,
CPA • Member, Executive Committee -
John A. Roberts,
MBA • Member, Executive Committee -
Rebecca Vermeulen,
RPh • Member, Executive Committee -
Barbara Lopez Kunz,
MS • Member, Executive Committee
-
Michael Romano,
CPA • Chair, Audit Committee -
Andrzej Czarnecki,
MD, PhD, DSc • Member, Audit Committee -
Angelika Joos,
MPharm • Member, Audit Committee -
Joseph Scheeren,
PharmD • Member, Audit Committee -
Cynthia L. Verst,
PharmD • Member, Audit Committee
-
Yoshiaki Uyama,
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
Peter Bachmann,
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
Gerald J. Dal Pan,
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
Petra Dörr,
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
Barbara Lopez Kunz,
MS • Global Chief Executive -
Bayard G. Gardineer,
MS, CPA • Chief Financial Officer -
Timothy Hess • Global Director of IT
-
Thomas Bols • Senior Vice President & Managing Director
DIA EMEA -
Youngshin Lee,
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
Sudip S. Parikh,
PhD • Senior Vice President & Managing Director
DIA Americas -
Akio Uemura,
PhD • Senior Vice President & Managing Director
DIA Japan -
Carol Zhu,
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China